GeneDx (WGS) is among the best performing small cap stocks for 2024, posting over 2600% gain. The company analyzes the complete DNA of a person, also known as the genome, composed of approximately ...

Childhood cancers are often difficult to detect, with symptoms that may appear vague or misleading. Traditional diagnostic tools, such as biopsies and microscopic tests, often fall short when dealing ...

GeneDx Holdings (WGS) shares were in focus after the company named Linda Genen, MD, MPH as Chief Medical Officer and highlighted a record year for its Medical Affairs and research programs in rare ...

GeneDx stock (NASDAQ: WGS) plunged 14% on Monday after the genomics testing company released preliminary full-year 2025 ...

When one-month-old Scout Bradstreet was diagnosed with a brain tumor, her world was turned upside down. The hospital became her second home, a place where she spent more time than anywhere else. "She ...

GeneDx Holdings Corp. (NASDAQ:WGS) is among the Best Genomics Stocks. TheFly reported that on December 22, 2025, GeneDx Holdings Corp. (NASDAQ:WGS) lifted its price objective at Canaccord from $160 to ...

Garden City, NY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics, therapeutics and diagnostics company, today ...

Demonstrating faster, simpler, more cost-efficient NGS workflows that turn complex agrigenomics data into practical ...